These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2857418)

  • 1. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders.
    Appleyard ST; Dunn MJ; Dubowitz V; Rose ML
    Lancet; 1985 Feb; 1(8425):361-3. PubMed ID: 2857418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of class I and class II MHC antigens in neuromuscular diseases.
    McDouall RM; Dunn MJ; Dubowitz V
    J Neurol Sci; 1989 Feb; 89(2-3):213-26. PubMed ID: 2926449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle expression of class II histocompatibility antigens (HLA-DR) in polymyositis and other muscle disorders with an inflammatory infiltrate.
    Zuk JA; Fletcher A
    J Clin Pathol; 1988 Apr; 41(4):410-4. PubMed ID: 3366926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-A & HLA-B antigens in multiple sclerosis, motor neuron disease & Duchenne muscular dystrophy.
    Mehta MM; Chablani UA; Contractor NM; Bhatia HM; Singhal BS; Mondkar VP; Desai AD
    Indian J Med Res; 1986 May; 83():519-21. PubMed ID: 3733208
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies to human leucocyte antigens in polymyositis and muscular dystrophy.
    Rowe D; Isenberg DA; Beverley PC
    Clin Exp Immunol; 1983 Nov; 54(2):327-36. PubMed ID: 6228350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical localisation of complement components C8 and C9 in human diseased muscle. The role of complement in muscle fibre damage.
    Sewry CA; Dubowitz V; Abraha A; Luzio JP; Campbell AK
    J Neurol Sci; 1987 Nov; 81(2-3):141-53. PubMed ID: 3694223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin and significance of small muscle fibres in neuromuscular disease.
    Tang LM; Swash M
    Virchows Arch A Pathol Anat Histopathol; 1986; 410(2):113-8. PubMed ID: 2948318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy.
    Isenberg DA; Rowe D; Shearer M; Novick D; Beverley PC
    Clin Exp Immunol; 1986 Feb; 63(2):450-8. PubMed ID: 2421951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vacuolar myositis with expression of both MHC class I and class II antigens on skeletal muscle fibers.
    Higuchi I; Nerenberg M; Ijichi T; Fukunaga H; Arimura K; Usuki F; Kuriyama M; Osame M
    J Neurol Sci; 1991 Nov; 106(1):60-6. PubMed ID: 1779240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory changes in affected muscles of facioscapulohumeral dystrophy.
    Honda H; Mano Y; Takahashi A
    J Neurol; 1987 Aug; 234(6):408-11. PubMed ID: 3655843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor receptor immunoreactivity on the tunica adventitia of intramuscular blood vessels in childhood muscular dystrophies.
    Zhao J; Yoshioka K; Miike T; Kageshita T; Arao T
    Neuromuscul Disord; 1991; 1(2):135-41. PubMed ID: 1668370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis.
    Tidball JG; Wehling-Henricks M
    Curr Opin Rheumatol; 2005 Nov; 17(6):707-13. PubMed ID: 16224247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy.
    Dastur DK; Razzak ZA
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):399-410. PubMed ID: 4714102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies.
    Spuler S; Engel AG
    Neurology; 1998 Jan; 50(1):41-6. PubMed ID: 9443455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies.
    Emslie-Smith AM; Arahata K; Engel AG
    Hum Pathol; 1989 Mar; 20(3):224-31. PubMed ID: 2470663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy.
    Askanas V; Serdaroglu P; Engel WK; Alvarez RB
    Neurosci Lett; 1991 Sep; 130(1):73-6. PubMed ID: 1660975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin and beta-amyloid-protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy: an immunocytochemical study.
    Leclerc A; Tomé FM; Fardeau M
    Neuromuscul Disord; 1993 Jul; 3(4):283-91. PubMed ID: 8268725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions.
    Behrens L; Kerschensteiner M; Misgeld T; Goebels N; Wekerle H; Hohlfeld R
    J Immunol; 1998 Dec; 161(11):5943-51. PubMed ID: 9834075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin-C expression correlates with macrophage invasion in Duchenne muscular dystrophy and in myositis.
    Gullberg D; Velling T; Sjöberg G; Salmivirta K; Gaggero B; Tiger CF; Edström L; Sejersen T
    Neuromuscul Disord; 1997 Jan; 7(1):39-54. PubMed ID: 9132139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.